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Edited by Christos StournarasAbstract Villin is a tissue-speciﬁc actin modifying protein that
is associated with actin ﬁlaments in the microvilli and terminal
web of epithelial cells. It belongs to a large family of actin-bind-
ing proteins which includes actin-capping, -nucleating and/or -
severing proteins such as gelsolin, severin, fragmin, adseverin/
scinderin and actin crosslinking proteins such as dematin and
supervillin. Studies done in epithelial cell lines and villin
knock-out mice have demonstrated the function of villin in regu-
lating actin dynamics, cell morphology, epithelial-to-mesenchy-
mal transition, cell migration and cell survival. In addition, the
ligand-binding properties of villin (F-actin, G-actin, calcium,
phospholipids and phospholipase C-c1) are mechanistically
important for the crosstalk between signaling pathways and actin
reorganization in epithelial cells.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Cell migration; Apoptosis1. Villin is an epithelial cell-speciﬁc actin regulatory protein
Epithelial cells display distinct structural and functional
attributes, which warrants examining their biological function
independently from that of non-polarized cells. Epithelial cells
form continuous mono- or multilayered sheets of tightly adher-
ent cells. These cells have characteristic structures that deter-
mine cell–cell contacts called the tight junction complex and
equally complex structure that regulates contacts with the cellu-
lar basement membranes called hemidesmosomes. During
development these cells emerge as non-polarized cells and dif-
ferentiate into polarized cells. One of the major functions of
epithelial cells is to serve as a physiological and structural bar-
rier. In addition, most epithelial cells participate in vectorial
transport of ions, solutes and water. Epithelial cells exhibit aAbbreviations: DSS, dextran sodium sulfate; EMT, epithelial-to-
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doi:10.1016/j.febslet.2008.02.040characteristic cell surface organization that is well adapted
for these specialized functions. All these roles of the epithelia
depend on the polarized distribution of proteins and lipids be-
tween the apical and basolateral membrane domains. The api-
cal surface of many epithelial cells have a distinctive
morphology consisting of extensions of uniform diameter with
a core of crosslinked actin ﬁlaments, called the brush border or
the microvilli. The microvilli are believed to increase the cell
surface area thus regulating the absorptive and secretory func-
tions of these cells. Actin ﬁlaments in epithelial cells are local-
ized predominantly at the apical surface. The actin
cytoskeletal structure of the apical membrane consists of the
microvillus core, the terminal web that underlies the apical plas-
ma membrane and the tight junction complex that determines
cell–cell adhesion. The apical cytoskeleton of epithelial cells is
also unique in that it is characterized by the absence of micro-
tubules and intermediate ﬁlaments. The exclusive expression of
microﬁlaments at the apical surface of epithelial cells under-
scores the relevance of actin and actin-binding proteins in the
regulation of epithelial cell function. A distinct spatial and
functional polarity in the actin isoforms has also been noted
in epithelial cells. For instance, in gastric parietal cells, b-actin
facilitates the fusion of tubulovesicles with the apical mem-
brane, thus regulating acid secretion by these cells [1]. There
is growing evidence for the involvement of microﬁlaments in
the organization and function of cell membranes. Likewise,
membrane-bound proteins and lipids act to regulate the micro-
ﬁlament structure. Several actin-binding proteins of the micro-
villar compartments have been identiﬁed as phospholipid-
binding proteins. The best examples of this include villin [2]
and ezrin [3] (reviewed in [4]). It is speculated that actin-binding
proteins determine the cell shape and thus plasma membrane
surface available for the ion transport proteins. Alternatively,
it has been suggested that the interaction of actin-binding pro-
teins with the plasma membrane may help stabilize the lipid bi-
layer which contains the ion transporting molecules. This
intimate interaction between the apical microﬁlament and the
plasma membrane also regulates traﬃcking of vesicles to and
from the apical membrane (reviewed in [5]). It is worth noting
that there are several actin regulatory proteins that are solely
expressed in epithelial cells, such as villin. We suggest that
understanding the regulation of epithelial cell function in the
context of these speciﬁc proteins is imperative to our apprecia-
tion of epithelial cell physiology and pathophysiology.
Another characteristic property of epithelial cells is their
ability to undergo a reversible process called ‘‘epithelial-to-blished by Elsevier B.V. All rights reserved.
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epithelial cell gene expression program and phenotype coinci-
dent with the acquisition of a mesenchymal phenotype. EMT
is physiologically relevant during embryogenesis and in adult
tissue for wound healing. However, EMT is also associated
with tumor metastasis. It is worth mentioning that greater than
90% of all tumors are carcinomas and the current thinking is
that all carcinoma cells undergo either partial or complete
EMT in order to become motile and invasive. The way epithe-
lial cells move both in vitro and during tumor metastasis is it-
self diﬀerent from non-epithelial cells such as ﬁbroblasts. First,
in vitro most epithelial cells migrate at signiﬁcantly lower
speeds than non-epithelial cells such as ﬁbroblasts. Second,
epithelial cells, in vitro, move as sheets maintaining cell–cell
contact. Third, epithelial cells at the wound edge undergo
EMT. Interestingly only the neoplastic cells at the outer edge
of the epithelial tumor mass undergo EMT, conﬁrming the role
of the stroma in inducing EMT. The reversibility of EMT indi-
cates that it is triggered by heterotypic signals originating from
stromal cells, suggesting an intimate communication between
the epithelial cells and the surrounding stroma. The mechanis-
tic basis of these stromal–epithelial interactions is poorly
understood, but growth factors are believed to mediate these
cell–cell interactions. Normal epithelial tissue homeostasis de-
pends on the communication between the epithelia and the
stromal compartments. This interaction between the mesen-
chyme, epithelia and the stroma is an important regulatory
mechanism required for organ development. The molecular
basis of endodermal diﬀerentiation and its interaction with
the mesoderm have been best studied in the development of
the mature intestine. In most organs, the mesenchymal cells
are found below the epithelia and the exchange of signals be-
tween these two cell compartments drives growth and diﬀeren-
tiation during organ development. The current thinking is that
signaling pathways relevant to organogenesis are recapitulated
during oncogenesis. Not surprisingly, defects in epithelial func-
tion and growth control play a major role in human diseases.
Most epithelial tissue also self-renew throughout adult life due
to the presence of multipotent stem cells and/or unipotent pro-
genitor cells. Epithelial stem cells are speciﬁed during develop-
ment and are controlled by epithelial–mesenchymal
interactions. Despite morphological and functional diﬀerences
among epithelia, common signaling pathways appear to con-
trol epithelial stem cell maintenance, activation, lineage deter-
mination, and diﬀerentiation. Additionally, deregulation of
these pathways can lead to diseases including cancer.
While the diﬀerences between epithelial and non-epithelial
cells itself deserves a separate discussion, it is clear from these
examples that epithelial morphology and function is far more
complex than that of non-epithelial cells. In this review, we
highlight how villin, an epithelial cell-speciﬁc actin-binding
protein is uniquely adapted to regulate the epithelial cell struc-
ture and function and describe how villin regulates the charac-
teristic features of the epithelia in which it is expressed, in
molecular terms. Villin is an epithelial cell-speciﬁc actin-bind-
ing protein that has been identiﬁed in very signiﬁcant amounts
in the gastrointestinal, renal and urogenital epithelial cells.
However, villin has also been identiﬁed in exocrine glands of
endodermic lineage such as the thymus and other epithelial cells
such as brush cells that line the respiratory tract, taste receptor
cells and osteocytes (reviewed in [6]). Then again, villin is also
expressed in cells that do not form microvilli-like structuressuch as crypt and M cells in the intestine. It is quite likely that
villin is expressed in many other epithelial cell types. Most of
these cells are either functionally similar or share a common
embryonic origin. In the gastrointestinal tract, it has been noted
that villin expression increases as the cells diﬀerentiate and
move from the crypt to the tip of the villi. A similar observation
has been made in intestinal cell lines in culture [7]. Villin is de-
tected in the immature digestive tract and there is a signiﬁcant
increase in the expression of villin prior to the formation of the
microvilli, thus villin is regarded as an early marker of commit-
ted intestinal absorptive cells. Villin is also considered as an
early marker of endodermal cell lineage and as a marker of cells
that arise from mesenchymal/epithelial conversion in the devel-
oping kidney. More recent studies have demonstrated that vil-
lin responds to morphogenetic cues associated with intestinal
and renal development. The expression of villin is maintained
in all carcinomas derived from tissue that normally express this
gene. In addition, the expression of villin has also been associ-
ated with intestinal metaplasia, implicating a role for villin in
the development of preneoplastic lesions [8,9].2. Villin as a regulator of actin dynamics
Villin is an unusually versatile actin modifying protein in
that it can both polymerize and depolymerize actin ﬁlaments.
It is an actin-capping, -severing, -nucleating and -bundling
protein. To the best of our knowledge, no other actin-binding
protein has been identiﬁed so far that retains all the actin mod-
ifying functions like villin. Structurally and functionally villin
can be compared to two groups of actin-binding proteins.
The ﬁrst includes proteins that nucleate, cap and/or sever actin
ﬁlaments and contain repeats of a conserved domain (Fig. 1).
The smallest protein of this family, severin contains three of
these conserved domains (S1–S3). Villin and the homologous
protein gelsolin contain six such repeats (S1–S6). This forms
the ‘‘core’’ of the villin protein. The second group includes pro-
teins that share a villin-like carboxyl-terminal domain called
the ‘‘headpiece’’ and includes proteins like dematin, supervillin
and advillin (Fig. 1). Most but not all proteins that share villin-
like headpiece crosslink actin ﬁlaments. This unique structure
of villin which includes both the core and the headpiece is
responsible for its ability to nucleate, cap, sever and crosslink
actin ﬁlaments (Fig. 2). Thus, understanding the molecular
mechanisms of villins function can help elucidate the func-
tional properties of a large family of structurally and function-
ally related proteins.
Actin binding by villin is completely dependent on Ca2+.
Two F-actin binding sites, one in the core and the second in
the headpiece, have been identiﬁed in villin (Fig. 2). Villins
association with F-actin is regulated by tyrosine phosphoryla-
tion of villin, which decreases the aﬃnity of villin for F-actin
[10]. In addition, other F-actin binding proteins such as tropo-
myosin can inhibit villins association with F-actin [11]. Two
monomer-binding sites are estimated in the villin core on the
basis of the monomer-binding sites identiﬁed in the homolo-
gous protein gelsolin (in domains S1 and S4). However, the
identity of these sites has not been conﬁrmed in villin, either
by mutational analysis or functionally. Villin binds the barbed
ends of actin ﬁlaments with very high aﬃnity (binding constant
of 1011 M1) thus capping actin ﬁlaments [12]. In vitro,
Fig. 1. Domain structure of the villin superfamily. The amino-terminal homologous domains conserved between villin ‘‘core’’ and other members of
the villin superfamily are numbered 1–6. The smallest proteins of this family include severin, fragmin and CapG which contain three of these
conserved domains (S1–S3). Villin and gelsolin contain all six of these domains (S1–S6), while EhABPH and ﬂightless-1 do not have S1 and S6
domains respectively. In addition, villin and EhABPH contain the ‘‘headpiece’’ domain (HP). The headpiece (HP) domain is also conserved in
proteins like supervillin, advillin, protovillin, villidin and dematin.
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trations between 10 and 30 nM [13]. In the presence of calcium,
villin also binds monomeric actin thus nucleating actin assem-
bly from the pointed ends of ﬁlaments. In vitro, at very high
calcium concentrations (100–200 lM) villin also severs actin
ﬁlaments [14]. Alternatively, tyrosine phosphorylated villin
severs actin at nanomolar calcium concentrations [15]. This
suggests that tyrosine phosphorylation rather than high cal-
cium may be the mechanism by which villin severs actin
in vivo. At an actin:villin ratio of 4:10, villin bundles actin ﬁl-
aments. While previous studies have suggested that both the F-
actin binding sites in villin are required for it to crosslink actin
ﬁlaments, we have recently reported that only the F-actin bind-
ing site in the headpiece participates in actin bundling by villin
[16]. However, villin self-associates to exhibit actin bundling
using a single F-actin binding site [16]. A detailed functional
analysis of villin mutants allowed us to demonstrate that the
exclusive function of the F-actin binding site in the core is to
sever actin ﬁlaments while the F-actin binding site in the head-
piece only bundles actin ﬁlaments [16]. These studies provided
a more physiologically relevant model for these morphologi-
cally distinct functions of villin in cells. The actin-capping
function of villin is contained within the ﬁrst (S1) domain of
villin [17]. In contrast, the entire villin core is required for actin
nucleation by villin [17]. It is speculated that the actin-capping
activity of villin is regulated by the monomer binding site in
domain S1, while the actin-nucleating activity is regulated by
both monomer-binding sites in domains S1 and S4 (reviewed
in [6]). Mutational analysis has conﬁrmed the identity of these
functional domains which were previously studied in proteo-
lytic fragments of villin or characterized biochemically. A clus-ter of basic amino acid residues (Arg-138, Lys-143 and Lys-145
in human villin) have been identiﬁed as the F-actin binding res-
idues in the villin core [18]. The identity of the F-actin binding
residues in the headpiece was ﬁrst described by Friederich et al.
[19] again as a cluster of basic amino acid residues with the
821KKEK824 motif. However, high-resolution crystal structure
and NMR structures of chicken villin headpiece have led to the
identiﬁcation of F-actin binding residues that do not include
this motif. These recent studies describe the F-actin binding
site in the headpiece to include a ‘‘hydrophobic cap’’ consisting
of Arg-787, Lys-815 and Lys-816 (in human villin) and a
‘‘crown’’ of positive and negative charges which includes
Lys-789 [20,21]. In the same study it was demonstrated that
Glu-823 and Lys-824 (in the KKEK motif) do not contribute
to actin binding by the headpiece [20].
The ligand-binding properties of villin as well as post-trans-
lational modiﬁcation of villin allow it to discriminate between
its two disparate actin modifying functions. The actin modi-
fying functions of villin are regulated by calcium, phosphoin-
ositides and by tyrosine phosphorylation of the villin protein.
The actin-capping function of villin is regulated by calcium
(increases it) and phosphatidylinositol 4,5-bisphosphate
(PIP2) (decreases it) [2,22]. The actin-nucleating activity of
villin is inhibited by tyrosine phosphorylation and calcium
is required for villin to nucleate actin ﬁlaments [10,13]. Actin
severing is enhanced by calcium (at concentration between
100 and 200 lM) and by tyrosine phosphorylation of villin,
which allows villin to sever actin at much lower calcium con-
centrations (nM) [13,15]. Actin severing by villin is inhibited
by direct association of villin with PIP2 [2]. The actin-bun-
dling function of villin is enhanced by villins interaction with
Fig. 2. Schematic representation of the domain structures of villin. The six homologous domains conserved between villin and other proteins of its
family are denoted by numbers S1–S6. Villin contains two F-actin domains one in the villin core and the second in the headpiece. The putative
monomer (G-actin) binding sites in villin are shown in S1 and S4. The F-actin domain in the core regulates actin severing while the F-actin domain in
the headpiece regulates actin crosslinking by villin. Actin bundling by villin also requires its self-association. The villin dimerization domain is shown
in the amino-terminal region (between residues 21–67 and 112–119 in human villin). The phospholipid-binding domains are indicated as PB1, PB2
and PB5. In the absence of PIP2, PB1 participates in villin dimerization. PIP2 binding to PB2 inhibits actin-severing activity of villin, while PIP2
binding to PB5 enhances actin bundling by villin. Also shown in this ﬁgure are the calcium-sensitive sites identiﬁed in villin, the actin-capping, actin-
nucleating, actin-severing and actin-bundling domains identiﬁed in human villin protein.
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[2,10].
During embryogenesis, villin associates with the apical sur-
face of epithelial cells even before an actin-based cytoskeleton
is established in these cells. This suggests that villins apical dis-
tribution is not entirely determined by the microﬁlament den-
sity. We speculate that villin interacts with the plasma
membrane and may even participate in assembling the apical
microvillar core. In vitro, villin associates with phosphoinosi-
tides, which are concentrated in the inner leaﬂet of the plasma
membrane, with the following binding aﬃnity: PIP2 > PIP >
PI [2]. The dissociation constant for villin-PIP2 binding was
determined to be 39.4 lM. This suggests that villin in fact
has a much higher binding aﬃnity for PIP2 than phospholipase
C-gamma 1 (PLC-c1) has for PIP2. In accord with this, we
have demonstrated that in vitro, villin can inhibit PLC-c1
activity by sequestering its substrate, PIP2 [23]. A direct inter-
action of villin with PIP2 in living cells has also been noted by
us in ﬂuorescence resonance energy transfer (FRET) analysis
using super-enhanced yellowed ﬂuorescent protein (SEYFP)-
tagged villin and cerulean-tagged pleckstrin homology (PH)
domain of PLC-d1 (George, S.P. and Khurana, S. unpublished
observation). Three PIP2 binding sites have been identiﬁed in
villin (PB1, PB2 and PB5 between amino acids 112–119;
138–146 and 816–824 in human villin protein; Fig. 2) [2].The ﬁrst PIP2 binding site participates in villin self association,
in the absence of PIP2 [16]. The second PIP2 binding site, PB2,
overlaps with the F-actin binding site in the villin core. Consis-
tent with this observation, PIP2 binding to this site inhibits ac-
tin severing by villin [2,24]. We have reported that in vitro,
PIP2 enhances actin crosslinking by villin [2]. Based on our
more recent studies, we speculate that this is mediated by the
association of PIP2 with the headpiece PIP2-binding domain,
PB5 [16]. All three PIP2-binding sites in villin are also con-
served among related actin-binding proteins such as gelsolin,
scinderin, adseverin, CapG, supervillin, advillin, dematin and
pervin. The three PIP2-binding sites in villin consist of a cluster
of basic amino acid residues with the motif x4R/KxR/KR/K,
where x is any residue. The association of villin with PIP2 does
not result in global changes in the protein conformation, how-
ever in studies done with villin peptides encompassing PB1 and
PB5 signiﬁcant changes in the secondary structure were noted
upon PIP2 binding by these peptides [2]. The only actin mod-
ifying activity of villin that is not regulated by PIP2 is actin
nucleation [2]. More recently, we have also demonstrated the
direct interaction of villin with the more hydrophilic phospho-
lipid, lysophosphatidic acid (LPA) with a higher aﬃnity than
PIP2 (Kd of 22 lM) [25]. Interestingly, both PIP2 and LPA
compete for the same binding sites in villin, but unlike the
eﬀects of PIP2, the association of villin with LPA inhibits all
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villin with LPA could sequester LPA thus modifying not only
the actin organization in these cells but also LPA-induced
intracellular signaling. Alternatively, LPA could be a potent
intracellular modulator of actin reorganization in epithelial
cells.
Villin is a globular protein that like gelsolin exists in an auto-
inhibited conformation. Hesterberg and Weber [26] ﬁrst sug-
gested that villins association with calcium releases this
conformation by a ‘‘hinge mechanism’’. It is also speculated
that this calcium-induced conformational change exposes the
F-actin binding site in the villin core, thus regulating the ac-
tin-severing function of villin. Full-length villin associates with
Ca2+ with a Kd value of 80.5 lM, a stoichiometry of 6 and a
hill coeﬃcient of 1.2 [22]. In vitro studies have shown that
the calcium-binding sites in villin associated with actin severing
have a much lower aﬃnity than the calcium-binding sites reg-
ulating actin capping by villin [13,14]. Using mutational anal-
ysis, we identiﬁed two major calcium-sensitive sites in villin
that induce conformational changes in villin protein [22].
The ﬁrst site (Glu-25; Asp-44 and Glu-74) regulates the ac-
tin-capping and actin-severing activity of villin; while the sec-
ond site (Asp-86; Ala-93 and Asp-61) regulates only the
actin-severing function of villin [22]. Some of these calcium-Fig. 3. Schematic model representing the molecular mechanism of actin rem
villin. In response to receptor activation (epidermal growth factor, EGF bi
Activation of c-src results in the tyrosine phosphorylation of villin which enha
to the plasma membrane. Tyrosine phosphorylated villin dissociates from ph
domain of PLC-c1. This results in the catalytic activation of PLC-c1 at the pla
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), which results in
ER) further enhancing the actin-severing activity of villin. Actin severing b
membrane, thus enhancing cell migration.sensitive sites have since been conﬁrmed functionally in cells
[27].
Villin is tyrosine phosphorylated both in vitro and in vivo
[23,28]. Ten tyrosine phosphorylation sites have been identiﬁed
in human villin (Y-46, -60, -81, -256, -286, -324, -461, -555,
-604 and -725) [29,30]. All 10 sites are localized within the villin
core. The non-receptor tyrosine kinase c-src regulates the
phosphorylation of villin both in vitro and in cells [31].
Although a recent study has suggested that Janus kinase 3
phosphorylates villin, detailed analysis from our laboratory
have demonstrated that intestinal epithelial cell lines as well
as epithelial cells in mouse intestine do not express Jak3, con-
sistent with its identiﬁed limited expression in haematopoeitic
cells [31,32]. RT-PCR allowed us to demonstrate unequivo-
cally that the intestinal epithelial cell lines, HT-29/clone 19A
and Caco-2 cells used to demonstrate phosphorylation of villin
by Jak3, in fact, do not even express Jak3 mRNA, thus we
question the validity of this report [31]. Villins interaction with
actin is sensitive to monovalent salt concentrations, suggesting
that electrostatic interactions are required for this association
[17]. We have speculated that tyrosine phosphorylation
changes the surface charge distribution in villin thus inﬂuenc-
ing villin–actin interactions. Consistent with this, we have
shown a decrease in the binding aﬃnity of phosphorylatedodeling and catalytic activation of PLC-c1 by tyrosine phosphorylated
nding to its receptor, EGFR), c-src kinase and PLC-c1 are activated.
nces its actin depolymerizing functions. Activation of PLC-c1 recruits it
osphatidylinositol 4,5-bisphosphate (PIP2) and associates with the SH2
sma membrane. PLC-c1 activation generates other second messengers,
the release of calcium from intracellular stores (endoplasmic reticulum,
y villin generates new barbed ends for actin assembly at the plasma
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lins aﬃnity for its other ligands including PLC-c1 and PIP2.
While phosphorylation of villin is required for its association
with the Src homology 2 (SH2) domain of PLC-c1, tyrosine
phosphorylation prevents villins association with PIP2
[23,28,33]. Based on our in vitro studies we proposed a work-
ing model (Fig. 3) to demonstrate the crosstalk between villin-
regulated microﬁlament structure, the plasma membrane and
components of the transmembrane signaling network [23].
Subsequent studies from our laboratory as well as other labo-
ratories have conﬁrmed this model in both epithelial cell lines
as well as in animal studies [30,33–38].3. Villin as an actin-capping, actin-bundling and actin-severing
protein in epithelial cells
Studies done in renal and intestinal epithelial cell lines as
well as in villin-null mice have established the function of villin
in regulating actin dynamics, signal transduction, cell mor-
phology, epithelial-to-mesenchymal transition, cell migration,
cell invasion and cell survival (Fig. 4) [30,33,36–39]. In addi-
tion, it has been demonstrated that villins actin-severing func-
tion is required for the invasion and dissemination of
enteropathogens in the gastrointestinal tract [39]. These studies
point to the signiﬁcance of villin in both epithelial cell physiol-
ogy as well as pathophysiology. Overexpression of villin in
ﬁbroblasts and other villin-null cells results in signiﬁcant actin
reorganization, which includes the loss of stress ﬁbers and for-
mation of microvilli-like structures on the dorsal surface of
these cells [16,37,40,41]. As a result, there is a drastic change
in cell morphology from a ﬂat to a more rounded, epitheloid
cell shape [37]. Over two decades ago it was demonstrated that
simple mixtures of villin and F-actin form uniformly polarized
bundles similar to those seen in the brush border of epithelial
cells [42]. Thus, villin inherently has the ability to organize the
actin ﬁlaments into ordered bundles in cells by recruiting actin
ﬁlaments from other microﬁlament structures such as stress ﬁ-
bers. In epithelial cells, villin is the major protein associatedFig. 4. Biological functions regulated by villin in cells. Studies done in epithe
functions of villin to include regulation of actin dynamics, cell morphology,
migration, cell invasion and apoptosis.with the actin ﬁlaments in the microvillar core. Some villin is
also found in the rootlet area of the terminal web along with
gelsolin and scinderin, two related proteins of the villin family
[43]. The presence of three proteins of the same family with
overlapping functions, highlights the signiﬁcance of these pro-
teins to epithelial cell function. Studies done in developing
mice and chicken has demonstrated that villin is the ﬁrst major
actin-bundling protein that concentrates at the apical surface
of enterocytes [44,45]. Thus, villin plays a major role in the ini-
tiation, organization and formation of the microvilli [46,47].
Consistent with these observations, changes in the microvillar
structure have been noted in the microvilli of villin knock-out
mice, which are not as well organized as their wild-type litter-
mates [48]. More recently, the absence of villin and the con-
comitant structural defects in the microvilli have been
associated with biliary atresia-like disorder in children [49].
In these children with progressive cholestasis and liver failure,
structural abnormalities were noted within the microvilli of the
bile duct canaliculi which were determined to be due to a lack
of villin expression.
Recent studies from our laboratory have demonstrated that
villin self-association is required not only for its actin-bundling
function, but also for the apical targeting of villin protein and
for villin-induced loss of stress ﬁbers (presented at ‘‘The Amer-
ican Society for Cell Biology 47th Annual Meeting’’, Abstract
B86: Dimerization of villin is required for its apical localiza-
tion. George, S.P., Siddiqui, M.R. and Khurana, S.). The villin
dimerization site contains a conserved cysteine residue, which
could regulate palmitoylation of villin protein. We have previ-
ously demonstrated that tyrosine phosphorylated villin redis-
tributes to a Triton-soluble fraction of the plasma membrane
[28,30]. Hence, we speculate that tyrosine phosphorylation of
villin may target it to the plasma membrane while palmitoyla-
tion of villin may anchor it to the plasma membrane. Alterna-
tively, palmitoylation may drive the protein to the apical
surface where c-src kinase may phosphorylate villin protein.
If it is determined that villin is indeed palmitoylated, it would
also require us to re-examine the role of the PIP2-binding sites
identiﬁed in villin and their role in determining the associationlial cell lines and in villin knock-out mice have identiﬁed the biological
signal transduction, epithelial-to-mesenchymal transition (EMT), cell
2134 S. Khurana, S.P. George / FEBS Letters 582 (2008) 2128–2139of villin with the apical plasma membrane in epithelial cells.
For over two decades it has been theorized that PIP2-binding
domains in actin regulatory proteins, including villin, gelsolin
and ezrin, determine the interaction of the microﬁlament struc-
ture with the plasma membrane. In that event, we would spec-
ulate that the major function of these sites would be to
sequester PIP2, thus regulating phosphoinositide-mediated sig-
nal transduction pathways, including the regulation of second
messengers such as PLC-c1, which is a known ligand for both
villin and its related protein, gelsolin [50]. Alternatively, the
association of villin with PIP2 rich domains in the plasma
membrane could lead to spatial clustering of villin in the vicin-
ity of other ligands thus regulating cell surface functions of epi-
thelial cells. The increase in stress ﬁbers noted in mutant cell
lines expressing the dimerization mutant of villin, may be re-
lated to villins actin-capping function. We have previously
identiﬁed a calcium-sensitive site in the NH2-terminal domain
of villin that regulates the actin-capping function of villin
(Glu-25, Asp-44 and Glu-74) [22]. Two of these three amino
acids are deleted in the dimerization mutant (D21–67/112–
119) [16]. Based on our preliminary studies, we would suggest
that loss of actin capping by villin would increase the F-actin
levels in the cells, thus altering actin ﬁlament dynamics in mu-
tant cell lines. Since overexpression of villin is associated with
loss of stress ﬁbers, we speculate that the actin-capping func-
tion of villin serves to suppress excess formation of F-actin.
Thus, the capping and uncapping of ﬁlament ends by villin
may spatially and temporally control actin polymerization in
epithelial cells. Villin expression in epithelial cells may as a
result, serve to regulate the cellular levels of F-actin. The
actin-capping function of villin is regulated by physiological
calcium concentrations (see discussion above) and may there-
fore be an innate function of villin, like its ability to crosslink
actin ﬁlaments. Another role of villin may be to regulate the
proper distribution of F-actin ﬁlaments in cells. Villin dimer-
ization mutant localizes to the basal surface of polarized epi-
thelial cells, increasing F-actin assembly at the ventral
surface of cells. Cells expressing the villin dimerization mutant
form lamellipodia like cells expressing wild-type villin protein,
yet the mutant cell lines do not migrate at the same rate as cells
expressing the wild-type protein. Loss of cell migration func-
tion of villin by this mutant may also be related to the loss
of actin capping by villin. These studies identify potentially
new and previously unrecognized functions of villin in epithe-
lial cells.
For more than two decades, villins physiological function
was believed to be limited to actin-bundling, despite the fact
that in vitro it can sever, cap and nucleate actin ﬁlaments. This
idea was based on the fact that to sever actin, villin requires
very high calcium concentrations (100–200 lM) that are not
physiologically appropriate. Our laboratory was the ﬁrst to
identify the tyrosine phosphorylation of villin and to report
that phosphorylation of villin enhanced the actin-severing
activity of villin even in the absence of high calcium [15,28].
Our in vitro studies were later conﬁrmed in the villin-null mice
which were shown to have an actin-severing defect [51]. It must
be pointed out that villin is the only actin-severing protein that
is expressed in the microvilli. Subsequently it was demon-
strated that the actin-severing activity of villin in mice required
tyrosine phosphorylation of villin [36]. These studies in villin-
null mice provided a temporal relationship between tyrosine
phosphorylation of villin and actin severing by villin. Usingvillin mutants that lack the tyrosine phosphorylation sites,
we provided a causal link between tyrosine phosphorylation
of villin and regulation of villins severing function in cells
[30,33,37,38].
Like other proteins of its family such as gelsolin, overexpres-
sion of villin increases cell motility, irrespective of the cell type
[33,37]. The absence of villin (in mice) as well as the overex-
pression of villin phosphorylation site mutants (in intestinal
epithelial cell lines) are both associated with an inhibition of
intestinal cell migration [33,36]. Nine of the 10 tyrosine phos-
phorylation sites identiﬁed in villin are required for its function
in cell migration. Three NH2-terminal residues in human villin
namely Y60, -81 and -256, are required for villins intracellular
distribution at the cell surface [37]. Villin mutants that failed to
localize at the cell margin, failed to increase cell migration [37].
In addition, six COOH-terminal tyrosine phosphorylation sites
are required for villins interaction with the SH2 domain of
PLC-c1 and for villin-induced increase in cell migration [30].
The direct interaction of phosphorylated villin with PLC-c1
was demonstrated by FRET analysis in live cells [33]. Further,
using PLC-c=1 ﬁbroblasts, we demonstrated that tyrosine
phosphorylation of villin alone is not suﬃcient for its function
in cell migration. The interaction of phosphorylated villin with
PLC-c1 and the catalytic activation of PLC-c1 by villin are
essential to its function in cell migration and cell invasion
[30,33]. The most crucial event in cell migration is rapid actin
polymerization and formation of a pseudopod in the direction
of cell movement. Actin polymerization can be initiated either
by uncapping of barbed ends of ﬁlaments or by actin severing
that generates new barbed ends. Tyrosine phosphorylation is
required for both actin severing by villin as well as regulation
of cell migration by villin [10,30,37]. Tyrosine phosphorylation
of villin enhances its actin-severing activity thus generating
new barbed ends for actin ﬁlament assembly and formation
of lamellipodia. Another important step in cell locomotion is
development of cell polarity. PLC-c1 has been implicated in
this ﬁrst step of cell migration [52]. Since villin-induced cell
migration also requires PLC-c1 and since villin can regulate
the catalytic activation of PLC-c1, we have suggested that
the synergistic interaction between PLC-c1 and villin regulates
the initial changes in the generation of free barbed ends, thus
regulating cell migration (Fig. 5) [23,30,33].
Src proteins play a critical role in the proliferation and dif-
ferentiation of normal intestinal epithelial cells [53]. Src activa-
tion is also evident in 80% of human colon cancers,
particularly those that metastasize to the liver [54–56]. Despite
the fact that there is considerable evidence associating aberrant
Src activation with the development and progression of colo-
rectal cancer and even though Src kinase inhibitors have en-
tered phase I clinical trials, there are surprisingly few studies
that have analyzed the consequences of Src activation on intes-
tinal epithelial cell function. There are also no reports of com-
plementary mechanistic studies to correlate the contribution of
the diﬀerent Src kinases (c-src, c-yes and c-fyn) in the regula-
tion of intestinal epithelial cell function. One of the major
functions of Src kinases is to modulate the actin cytoskeleton
that controls cell migration [57]. However, the exact mecha-
nism by which Src proteins induce remodeling of the actin
cytoskeleton remains unknown. By examining the phosphory-
lation of villin by these three ubiquitously expressed Src kinase
and correlating these with changes in cell behavior and signal-
ing, we have provided a biochemical and cellular model that
Fig. 5. Stimulated protrusion model showing the synergistic interaction of villin with PLC-c1 in the regulation of cell migration. (1) Under resting
condition, villin is not activated. (2) The localized activation of villin generates free barbed ends. (3) Proﬁlin bound ATP-G-actin is added to the
barbed end, generating ATP actin caps, where activated Arp2/3 complex binds and initiates branch formation. (4) Rapid growth occurs at the barbed
end of actin ﬁlaments which pushes the membrane forward. Translocation of PLC-c1 to the plasma membrane initiates the early steps involved in
actin polymerization and assembly by deﬁning the directionality of a polarized motile cell.
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activation. Using the c-src, c-yes and c-fyn null ﬁbroblast
transfected individually with the ubiquitously expressed Src ki-
nases we have recently reported that c-src kinase but not c-yes
or c-fyn is required for villin-induced increase in cell migration
[31]. Further, we determined that two protein tyrosine phos-
phatases, SHP-2 and PTP-PEST negatively regulate villins
function in cell migration by dephosphorylating c-src kinase
at the catalytically active tyrosine residue Y416 within the ki-
nase domain of c-src, thus preventing the phosphorylation of
villin by c-src kinase. Both SHP-2 and PTP-PEST have been
shown to reduce carcinoma invasiveness-related properties of
cells in vitro [58,59]. Whether, villin-induced increase in cell
migration and cell invasiveness is aberrantly regulated by c-
src kinase during colon cancer progression and whether it con-
tributes to colon tumor invasion and metastasis remains to be
investigated in the future. However, we have reported that
attenuation of c-src kinase activity as well as inhibition of villin
phosphorylation can inhibit migration of human adenocarci-
noma cells [31,33]. Caco-2 cells are human adenocarcinoma
cells that endogenously express villin. Overexpression of dom-
inant negative c-src kinase or treatment with the Src kinase
inhibitor PP2; overexpression of SHP-2 or PTP-PEST; down-
regulation of PLC-c1 with PLC-c1 siRNA or the PLC-c1 inhib-
itor U73122 all inhibit Caco-2 cell migration, consistent with
the model described by us for villin-induced cell motility
(Fig. 5) [31,33,38]. Likewise, overexpression of a phosphoryla-
tion site mutant of villin in Caco-2 cells had a dominant neg-ative eﬀect, inhibiting both basal as well as growth factor
induced cell migration, conﬁrming that downregulation of c-
src kinase and PLC-c1 both inhibited cell migration by inhib-
iting villins function in Caco-2 cells [33]. Together, these data
suggest that in colorectal carcinogenesis, elevation of c-src may
promote cancer metastasis and invasion by regulating villin-in-
duced cell migration.4. Villin as an anti-apoptotic protein
Some of the most comprehensible data supporting links
between actin and apoptosis in eukaryotic cells come from
studies using drugs that aﬀect actin turnover. Actin and
actin-binding proteins are also substrates of activated caspases,
although it remains to be established if such changes are
important for the progression of the apoptotic process. In
yeast, however, it has been clearly demonstrated that changes
in actin turnover caused by direct mutations in actin, addition
of actin-binding drugs or by mutations in actin-binding pro-
teins changes cell fate [60]. Yeast with reduced actin dynamics
exhibit accumulation of F-actin, loss of mitochondrial perme-
ability and increased cell death. The precise mechanisms by
which alterations in actin dynamics regulate apoptosis in high-
er eukaryotes remains to be established. However, several
recent studies clearly support a role for actin dynamics in cell
survival. It has been suggested that actin ﬁlaments could regu-
late mitochondrial structure and function by regulating
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drial morphology (ﬁssion and fusion) and/or transport of pro-
apoptotic cargo to the mitochondria [61–66].
The best studied actin regulatory protein that is also associ-
ated with apoptosis is gelsolin, a homologous protein of the
villin family. The roles of gelsolin however, are disputed in
terms of its involvement in contrasting activities such as onco-
genic [67,68], anti-oncogenic [69,70], pro-apoptotic [71] and
anti-apoptotic [72,73]. Overexpression of gelsolin has been
shown to inhibit caspase-3 activation indicating its role as an
anti-apoptotic protein [74,75]. At the same time overexpression
of gelsolin has also been shown to fail to regulate lymphocyte
apoptosis [76]. To explain this disparity, it has been reported
that human gelsolin but not mouse gelsolin inhibits apoptosis,
although there are studies done with mouse gelsolin and its
anti-apoptotic eﬀects [73,77]. The most convincing data come
from two studies that have examined neurons and liver tissue
from gelsolin-null mice, and both these studies suggest that gel-
solin functions as an anti-apoptotic protein [78,79]. Our own
studies with the villin knock-out mouse and the villin and gel-
solin-double knock-out mice suggest that in vivo gelsolin func-
tions as an anti-apoptotic protein [80]. Gelsolin is also cleaved
by caspase-3 and the NH2-terminal cleaved fragment (S1–S3)
has been shown to enhance apoptosis while the COOH-termi-
nal fragment (S4–S6) has been shown to inhibit apoptosis
[71,81]. Again, the physiological relevance of these ﬁndings is
unclear. Both full-length gelsolin and fragment 5 (S5) of gelso-
lin have been shown to inhibit apoptosis by directly binding to
the voltage-dependent anion channels (VDAC) [72,81]. How-
ever, even this ﬁnding is undermined by a recent study by
Baines and colleagues that demonstrates unequivocally that
VDACs do not regulate mitochondrial apoptosis [82]. To fur-
ther complicate this picture, gelsolin in complex with PIP2 has
been shown to directly inhibit caspase-9 and -3 as well as pre-
vent apoptotic progression in a cell free system [73]. At the
same time gelsolin also inhibits Fas-triggered death signals,
which suggests that gelsolin prevents apoptosis by acting up-
stream of caspase activation. We believe our studies with villin
knock-out mice and with the villin-gelsolin double knock-out
mice provide an opportunity to not only understand epithelial
cell survival but also to introduce a molecular basis for gelso-
lins anti-apoptotic function in the gastrointestinal epithelium
that could be extended to other tissues.
The homeostatic balance between proliferation and apopto-
sis is essential for the intestinal epithelium to function as a
physiological and structural barrier. Intestinal epithelial cells
have a high rate of cell turnover accompanied by an equally
high rate of apoptosis [83]. This normal apoptosis is essential
for the hierarchical organization of the intestinal epithelium
and apoptotic epithelial cells have been detected both at the
base of the crypt as well as the villus tips of the small and large
intestine [84,85]. Defects in apoptosis are also associated with
several gastrointestinal disorders such as villus atrophy, epithe-
lial hyperplasia, loss of normal absorptive functions and in-
creased risk of tumorigenesis. Abnormalities in apoptotic
function contribute both to the pathogenesis of colorectal can-
cer as well as its resistance to chemotherapy and radiotherapy
[86,87]. Surprisingly, there are few data available on whether
apoptosis is an important mechanism of action in vivo in the
gastrointestinal epithelium. We have recently reported that
the villin-null mice have higher levels of apoptosis compared
to their wild-type littermates that correlates with the severityof colitis induced in dextran sodium sulfate (DSS)-treated vil-
lin-null mice [88]. Further in vitro experiments allowed us to
characterize villin as an epithelial cell-speciﬁc anti-apoptotic
protein. These studies provided a molecular mechanism for vil-
lins role in regulating epithelial cellular plasticity related to cell
injury [88]. We also determined from these studies that villin is
cleaved late in the apoptotic cycle (Wang, Y. and Khurana, S.,
unpublished observation) and we have previously reported that
an NH2-terminal fragment of villin is pro-apoptotic [30]. Based
on ongoing research in our laboratory, we speculate that full-
length villin is anti-apoptotic. However, as the epithelial cells
migrate from the crypt to the tip and are ready to be shed into
the lumen, villin may be cleaved to generate the pro-apoptotic
S1–S3 fragment thus enhancing and/or assisting the process of
cell extrusion from the gastrointestinal epithelium. To examine
the role of villin and its related proteins in the regulation of epi-
thelial cell survival, we have generated the villin-gelsolin double
knock-out mice [80]. The double knock-out mice have higher
levels of apoptotic cells compared to their wild-type littermates
[80]. Deletion of both genes resulted in increased susceptibility
of these mice to both c-radiation as well as DSS-colitis induced
apoptosis and injury [80]. Transmission electron micrographs
of the small intestine showed a dramatic change in the mito-
chondrial morphology in these mice, but not in wild-type or
the single knock-out mice. The mitochondria were swollen
and irregular with signiﬁcant loss of cristae structures and elec-
tron dense inclusions were noted within the inner membrane.
These mice had a large number of abnormal mitochondria
undergoing autophagy and a signiﬁcant increase in the accu-
mulation of lipofuscin [80]. All these ﬁndings are indicative
of perturbed mitochondrial morphology and function and pre-
dictive of lower ATP levels. These studies suggest that in vivo,
both villin and gelsolin function as anti-apoptotic proteins.
Further, these studies suggest that these proteins may have
overlapping functions in epithelial cell survival, since the phe-
notype of the villin-gelsolin double knock-out mouse is more
severe than that of either single knock-out mice [80,88]. A cor-
relation between absence of villin and increased apoptosis has
been noted in several inﬂammatory diseases of the gastrointes-
tinal tract. A decrease in the levels of villin expression in entero-
cytes from patients with inﬂammatory bowel disease relative to
healthy controls has been reported [89]. Evidence from animal
and human studies have demonstrated that increased apoptosis
in the intestinal epithelium contributes to the tissue damage
and the severity of colonic inﬂammatory response [85]. De-
creased villin expression has also been associated with other
inﬂammatory diseases such as pancreatitis, a disease believed
to be related to abnormal apoptosis/necrosis [90].
Changes in intracellular calcium, changes in actin cytoskele-
ton as well as activation of PI3-kinase all have been demon-
strated to regulate apoptosis in eukaryotic cells. Villin is an
actin-nucleating, -capping, -severing and -crosslinking protein
that also associates with Ca2+, PIP2 and PLC-c1. Any of these
properties of villin could thus regulate its anti-apoptotic func-
tions. We have used wild-type and mutant villin proteins lack-
ing each of these actin modifying or ligand-binding sites and
examined the eﬀects on epithelial cell survival. Our studies al-
lowed us to demonstrate unequivocally, that the actin-severing
function of villin was required for its anti-apoptotic function
[91]. Overexpression of either villin or gelsolin in epithelial cell
lines delayed apoptosis by maintaining the actin dynamics [91].
In contrast, in the absence of these proteins or in the presence
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cant increase in the F-actin content of cells accompanied by
a signiﬁcant decrease in the G-actin content of cells [91]. Thus,
our studies allow us to conclude that both villin and gelsolin
function as anti-apoptotic proteins by regulating actin dynam-
ics in cells. Further, the actin-severing functions of both these
proteins prevent the accumulation of F-actin in cells subjected
to apoptotic injury. It may be noted that both in yeast as well
as in eukaryotic cells, reduced actin dynamics and accumula-
tion of F-actin has been linked to increased cell death [60,92].5. Summary
Villin is an extraordinarily versatile actin regulatory protein
that organizes, integrates and regulates multiple epithelial cell
functions such as cell morphology, cell motility and cell death.
To perform these diverse biological functions villins actin
modifying activities are tightly regulated both spatially and
temporally. Villin responds to extracellular stimuli as well as
interacts with several second messengers including PIP2,
PLC-c1 and calcium, it is also a substrate of c-src kinase and
yet unidentiﬁed phosphatases. Thus, villin serves to converge
signals at the cell surface to regulate cell migration but also
intracellular to regulate cell survival. Understanding the
molecular mechanisms of villins function in cells allows us
to appreciate the synergy between actin-binding proteins and
signal transduction pathways in the regulation of biological
processes. While many potential drug targets are available to
treat human diseases, development of cytoskeleton-based
strategies to treat or prevent human disease is essentially un-
tapped. We believe our studies identify the actin cytoskeleton
as a target to protect from apoptosis and modify during metas-
tasis and thus may have implications for therapeutic ap-
proaches to digestive and renal diseases.
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